How p53 wields the scales of fate: Arrest or death?

Transcription

Volumn 3, Issue 5, 2012, Pages

  Goh, Amanda M ^a   Lane, David P ^a  

^a AGENCY FOR SCIENCE   (Singapore)

Author keywords

p53; Protein conformation; Reporter mouse models; Target gene selection; Tumor suppression

Indexed keywords

DNA; ENHANCED GREEN FLUORESCENT PROTEIN; PROTEIN P53; GREEN FLUORESCENT PROTEIN;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CARBOXY TERMINAL SEQUENCE; CELL CYCLE ARREST; CELL DEATH; CELL FATE; GENE EXPRESSION REGULATION; GENETIC SELECTION; HUMAN; NONHUMAN; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; SYSTEMS BIOLOGY; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE; ANIMAL; CELL CYCLE CHECKPOINT; CHEMISTRY; DNA RESPONSIVE ELEMENT; GENETICS; MOUSE; REPORTER MOUSE MODELS; TARGET GENE SELECTION;

MUS;

P53; PROTEIN CONFORMATION; REPORTER MOUSE MODELS; TARGET GENE SELECTION; TUMOR SUPPRESSION;

ANIMALS; CELL CYCLE CHECKPOINTS; CELL DEATH; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; MICE; MICE, TRANSGENIC; PROTEIN CONFORMATION; RESPONSE ELEMENTS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84866065842     PISSN: 21541264     EISSN: 21541272     Source Type: Journal    
DOI: 10.4161/trns.21297     Document Type: Article

References (31)

1. Vousden KH, Prives C. Blinded by the Light: The Growing Complexity of p53. Cell 2009; 137:413-31
2. el-Deiry WS, Tokino T, Velculescu VE, Levy DB,Parsons R, Trent JM, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75:817-25;PMID:8242752; http://dx.doi.org/10.1016/0092-8674(93)90500-P.
3. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75:817-25; PMID:8242752; http://dx.doi.org/10.1016/0092-8674(93)90500-P.
4. Yu J, Zhang L, Hwang PM, Kinzler KW, Vogelstein B. PUMA induces the rapid apoptosis of colorectal cancer cells. Mol Cell 2001; 7:673-82; PMID:11463391; http://dx.doi.org/10.1016/S1097-2765(01)00213-1.
5. Murray-Zmijewski F, Slee EA, Lu X. A complex barcode underlies the heterogeneous response of p53 to stress. Nat Rev Mol Cell Biol 2008; 9:702-12; PMID:18719709; http://dx.doi.org/10.1038/ nrm2451.
6. Zhao R, Gish K, Murphy M, Yin Y, Notterman D, Hoffman WH, et al. Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Dev 2000; 14:981-93; PMID:10783169.
7. Fei P, Bernhard EJ, El-Deiry WS. Tissue-specific induction of p53 targets in vivo. Cancer Res 2002; 62:7316-27; PMID:12499275.
8. Goh AM, Lim CY, Chiam PC, Li L, Mann MB, Mann KM, et al. Using targeted transgenic reporter mice to study promoter-specific p53 transcriptional activity. Proc Natl Acad Sci U S A 2012; 109:1685-90; PMID:22307631; http://dx.doi.org/10.1073/ pnas.1114173109.
9. Gottlieb E, Haffner R, King A, Asher G, Gruss P, Lonai P, et al. Transgenic mouse model for studying the transcriptional activity of the p53 protein: age-and tissue-dependent changes in radiation-induced activation during embryogenesis. EMBO J 1997; 16:1381-90; PMID:9135153; http://dx.doi. org/10.1093/emboj/16.6.1381.
10. Hamstra DA, Bhojani MS, Griffin LB, Laxman B, Ross BD, Rehemtulla A. Real-time evaluation of p53 oscillatory behavior in vivo using bioluminescent imaging. Cancer Res 2006; 66:7482-9; PMID:16885345; http://dx.doi.org/10.1158/0008-5472.CAN-06-1405.
11. Komarova EA, Chernov MV, Franks R, Wang K, Armin G, Zelnick CR, et al. Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo. EMBO J 1997; 16:1391-400; PMID:9135154; http://dx.doi.org/10.1093/emboj/16.6.1391.
12. Weinberg RL, Veprintsev DB, Bycroft M, Fersht AR. Comparative binding of p53 to its promoter and DNA recognition elements. J Mol Biol 2005; 348:589-96; PMID:15826656; http://dx.doi.org/10.1016/j.jmb.2005.03.014.
13. Melero R, Rajagopalan S, Lázaro M, Joerger AC, Brandt T, Veprintsev DB, et al. Electron microscopy studies on the quaternary structure of p53 reveal different binding modes for p53 tetramers in complex with DNA. Proc Natl Acad Sci U S A 2011; 108:557-62; PMID:21178074; http://dx.doi.org/10.1073/ pnas.1015520107.
14. el-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B. Definition of a consensus binding site for p53. Nat Genet 1992; 1:45-9; PMID:1301998; http://dx.doi.org/10.1038/ng0492-45.
15. Joerger AC, Fersht AR. The tumor suppressor p53: from structures to drug discovery. Cold Spring Harb Perspect Biol 2010; 2:a000919; PMID:20516128; http://dx.doi.org/10.1101/cshperspect.a000919.
16. Göhler T, Reimann M, Cherny D, Walter K, Warnecke G, Kim E, et al. Specific interaction of p53 with target binding sites is determined by DNA conformation and is regulated by the C-terminal domain. J Biol Chem 2002; 277:41192-203; PMID:12171916; http://dx.doi.org/10.1074/jbc.M202344200.
17. Shaked H, Shiff I, Kott-Gutkowski M, Siegfried Z, Haupt Y, Simon I. Chromatin immunoprecipitation-on-chip reveals stress-dependent p53 occupancy in primary normal cells but not in established cell lines. Cancer Res 2008; 68:9671-7; PMID:19047144; http://dx.doi.org/10.1158/0008-5472.CAN-08-0865.
18. Horn HF, Vousden KH. Coping with stress: multiple ways to activate p53. Oncogene 2007; 26:1306-16; PMID:17322916; http://dx.doi.org/10.1038/ sj.onc.1210263.
19. Huang F, Rajagopalan S, Settanni G, Marsh RJ, Armoogum DA, Nicolaou N, et al. Multiple conformations of full-length p53 detected with single-molecule fluorescence resonance energy transfer. Proc Natl Acad Sci U S A 2009; 106:20758-63; PMID:19933326; http://dx.doi.org/10.1073/ pnas.0909644106.
20. Feng H, Jenkins LM, Durell SR, Hayashi R, Mazur SJ, Cherry S, et al. Structural basis for p300 Taz2-p53 TAD1 binding and modulation by phosphorylation. Structure 2009; 17:202-10; PMID:19217391.
21. Natan E, Baloglu C, Pagel K, Freund SM, Morgner N, Robinson CV, et al. Interaction of the p53 DNA-binding domain with its n-terminal extension modulates the stability of the p53 tetramer. J Mol Biol 2011; 409:358-68; PMID:21457718; http://dx.doi. org/10.1016/j.jmb.2011.03.047.
22. Schlereth K, Beinoraviciute-Kellner R, Zeitlinger MK, Bretz AC, Sauer M, Charles JP, et al. DNA binding cooperativity of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol Cell 2010; 38:356-68; PMID:20471942; http://dx.doi.org/10.1016/j.molcel.2010.02.037.
23. Toledo F, Wahl GM. Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat Rev Cancer 2006; 6:909-23; PMID:17128209; http://dx.doi. org/10.1038/nrc2012.
24. Das S, Raj L, Zhao B, Kimura Y, Bernstein A, Aaronson SA, et al. Hzf Determines cell survival upon genotoxic stress by modulating p53 transactivation. Cell 2007; 130:624-37; PMID:17719541; http://dx.doi.org/10.1016/j.cell.2007.06.013.
25. Samuels-Lev Y, O'Connor DJ, Bergamaschi D, Trigiante G, Hsieh JK, Zhong S, et al. ASPP proteins specifically stimulate the apoptotic function of p53. Mol Cell 2001; 8:781-94; PMID:11684014; http://dx.doi.org/10.1016/S1097-2765(01)00367-7.
26. Espinosa JM, Emerson BM. Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment. Mol Cell 2001; 8:57-69; PMID:11511360; http://dx.doi.org/10.1016/S1097-2765(01)00283-0.
27. Gomes NP, Espinosa JM. Gene-specific repression of the p53 target gene PUMA via intragenic CTCF-Cohesin binding. Genes Dev 2010; 24:1022-34; PMID:20478995; http://dx.doi.org/10.1101/ gad.1881010.
28. París R, Henry RE, Stephens SJ, McBryde M, Espinosa JM. Multiple p53-independent gene silencing mechanisms define the cellular response to p53 activation. Cell Cycle 2008; 7:2427-33; PMID:18677110.
29. Morachis JM, Murawsky CM, Emerson BM. Regulation of the p53 transcriptional response by structurally diverse core promoters. Genes Dev 2010; 24:135-47; PMID:20040571; http://dx.doi. org/10.1101/gad.1856710.
30. Espinosa JM, Verdun RE, Emerson BM. p53 functions through stress-and promoter-specific recruitment of transcription initiation components before and after DNA damage. Mol Cell 2003; 12:1015-27; PMID:14580351; http://dx.doi.org/10.1016/S1097-2765(03)00359-9.
31. Gomes NP, Bjerke G, Llorente B, Szostek SA, Emerson BM, Espinosa JM. Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program. Genes Dev 2006; 20:601-12; PMID:16510875; http://dx.doi.org/10.1101/gad.1398206.